We were delighted to catch up with Farhad Hafezi (ELZA Institute, Zurich, Switzerland) about the disadvantages of performing corneal cross-linking procedures in the operating theatre, the potential to now perform epithelium-on cross-linking procedures at the slit lamp, and the implication of this on future practice.
Questions
- Could you give us an overview of epithelium-on cross-linking procedures at the slit lamp? (00:13)
- What are the beneficial effects of the procedure on the cornea? (01:45)
- What are the disadvantages of this procedure for the patient in terms of infection risks and discomfort for the patient? (02:20)
- How do you see the applications of this procedure developing in the future? (02:49
Speaker Disclosure: Farhad Hafezi holds patents and applications for corneal apparatus used for CXL, chromophore for CXL application; and is a shareholder and investor for EMAGine AG.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed in coverage of ESCRS 2021.
